Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 128

1.

Targeting the EphB4 receptor for cancer diagnosis and therapy monitoring.

Li D, Liu S, Liu R, Park R, Hughes L, Krasnoperov V, Gill PS, Li Z, Shan H, Conti PS.

Mol Pharm. 2013 Jan 7;10(1):329-36. doi: 10.1021/mp300461b. Epub 2012 Dec 18.

2.

PET imaging of colorectal and breast cancer by targeting EphB4 receptor with 64Cu-labeled hAb47 and hAb131 antibodies.

Liu S, Li D, Park R, Liu R, Xia Z, Guo J, Krasnoperov V, Gill PS, Li Z, Shan H, Conti PS.

J Nucl Med. 2013 Jul;54(7):1094-100. doi: 10.2967/jnumed.112.116822. Epub 2013 May 10. Review.

3.

EphB4-targeted imaging with antibody h131, h131-F(ab')2 and h131-Fab.

Li D, Liu S, Liu R, Zhou Y, Park R, Naga K, Krasnoperov V, Gill PS, Li Z, Shan H, Conti PS.

Mol Pharm. 2013 Dec 2;10(12):4527-33. doi: 10.1021/mp400354y. Epub 2013 Nov 7.

4.

Axl-targeted cancer imaging with humanized antibody h173.

Li D, Liu S, Liu R, Park R, Yu H, Krasnoperov V, Gill PS, Li Z, Shan H, Conti PS.

Mol Imaging Biol. 2014 Aug;16(4):511-8. doi: 10.1007/s11307-013-0714-z.

5.

Dual-modality micro-positron emission tomography/computed tomography and near-infrared fluorescence imaging of EphB4 in orthotopic glioblastoma xenograft models.

Huang M, Xiong C, Lu W, Zhang R, Zhou M, Huang Q, Weinberg J, Li C.

Mol Imaging Biol. 2014 Feb;16(1):74-84. doi: 10.1007/s11307-013-0674-3.

6.

Characterizing breast cancer xenograft epidermal growth factor receptor expression by using near-infrared optical imaging.

Wang K, Wang K, Li W, Huang T, Li R, Wang D, Shen B, Chen X.

Acta Radiol. 2009 Dec;50(10):1095-103. doi: 10.3109/02841850903008800.

7.

Cy5.5-Anti-ephrin receptor B4 (EphB4) humanized monoclonal antibody hAb47.

Leung K.

Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004-2013.
2013 Mar 18 [updated 2013 May 9].

8.

Near-infrared optical imaging of epidermal growth factor receptor in breast cancer xenografts.

Ke S, Wen X, Gurfinkel M, Charnsangavej C, Wallace S, Sevick-Muraca EM, Li C.

Cancer Res. 2003 Nov 15;63(22):7870-5.

9.

Novel EphB4 monoclonal antibodies modulate angiogenesis and inhibit tumor growth.

Krasnoperov V, Kumar SR, Ley E, Li X, Scehnet J, Liu R, Zozulya S, Gill PS.

Am J Pathol. 2010 Apr;176(4):2029-38. doi: 10.2353/ajpath.2010.090755. Epub 2010 Feb 4.

10.

Semiautomatic landmark-based two-dimensional-three-dimensional image fusion in living mice: correlation of near-infrared fluorescence imaging of Cy5.5-labeled antibodies with flat-panel volume computed tomography.

Dullin C, Zientkowska M, Napp J, Missbach-Guentner J, Krell HW, Müller F, Grabbe E, Tietze LF, Alves F.

Mol Imaging. 2009 Jan-Feb;8(1):2-14.

PMID:
19344571
11.

Tumor Targeting and Pharmacokinetics of a Near-Infrared Fluorescent-Labeled δ-Opioid Receptor Antagonist Agent, Dmt-Tic-Cy5.

Huynh AS, Estrella V, Stark VE, Cohen AS, Chen T, Casagni TJ, Josan JS, Lloyd MC, Johnson J, Kim J, Hruby VJ, Vagner J, Morse DL.

Mol Pharm. 2016 Feb 1;13(2):534-44. doi: 10.1021/acs.molpharmaceut.5b00760. Epub 2016 Jan 8.

12.

Evaluation of four affibody-based near-infrared fluorescent probes for optical imaging of epidermal growth factor receptor positive tumors.

Qi S, Miao Z, Liu H, Xu Y, Feng Y, Cheng Z.

Bioconjug Chem. 2012 Jun 20;23(6):1149-56. doi: 10.1021/bc200596a. Epub 2012 Jun 4.

PMID:
22621238
13.

In vivo NIRF imaging-guided delivery of a novel NGR-VEGI fusion protein for targeting tumor vasculature.

Ma W, Li G, Wang J, Yang W, Zhang Y, Conti PS, Chen K.

Amino Acids. 2014 Dec;46(12):2721-32. doi: 10.1007/s00726-014-1828-6. Epub 2014 Sep 3.

PMID:
25182731
14.

Tumor targeting chitosan nanoparticles for dual-modality optical/MR cancer imaging.

Nam T, Park S, Lee SY, Park K, Choi K, Song IC, Han MH, Leary JJ, Yuk SA, Kwon IC, Kim K, Jeong SY.

Bioconjug Chem. 2010 Apr 21;21(4):578-82. doi: 10.1021/bc900408z.

PMID:
20201550
15.

An HDAC-Targeted Imaging Probe LBH589-Cy5.5 for Tumor Detection and Therapy Evaluation.

Meng Q, Liu Z, Li F, Ma J, Wang H, Huan Y, Li Z.

Mol Pharm. 2015 Jul 6;12(7):2469-76. doi: 10.1021/acs.molpharmaceut.5b00167. Epub 2015 Jun 16.

PMID:
26030093
16.

Near-infrared fluorescent nanoparticles as combined MR/optical imaging probes.

Josephson L, Kircher MF, Mahmood U, Tang Y, Weissleder R.

Bioconjug Chem. 2002 May-Jun;13(3):554-60.

PMID:
12009946
17.

Near-infrared fluorescence imaging of non-Hodgkin's lymphoma CD20 expression using Cy7-conjugated obinutuzumab.

Lin X, Zhu H, Luo Z, Hong Y, Zhang H, Liu X, Ding H, Tian H, Yang Z.

Mol Imaging Biol. 2014 Dec;16(6):877-87. doi: 10.1007/s11307-014-0742-3.

PMID:
24833041
18.

Near-infrared fluorescent deoxyglucose analogue for tumor optical imaging in cell culture and living mice.

Cheng Z, Levi J, Xiong Z, Gheysens O, Keren S, Chen X, Gambhir SS.

Bioconjug Chem. 2006 May-Jun;17(3):662-9.

19.

In vivo imaging of mesenchymal-epithelial transition factor (c-Met) expression using an optical imaging system.

Kim EM, Park EH, Cheong SJ, Lee CM, Jeong HJ, Kim DW, Lim ST, Sohn MH.

Bioconjug Chem. 2009 Jul;20(7):1299-306. doi: 10.1021/bc8005539.

PMID:
19534520
20.

Optical antisense imaging of tumor with fluorescent DNA duplexes.

Liu X, Wang Y, Nakamura K, Liu G, Dou S, Kubo A, Rusckowski M, Hnatowich DJ.

Bioconjug Chem. 2007 Nov-Dec;18(6):1905-11. Epub 2007 Oct 17.

PMID:
17939728

Supplemental Content

Support Center